U.S. Healthtech Stock News

Raymond James just upgraded Genuine Parts (GPC) to Strong Buy after the company outlined plans to separate its automotive and industrial businesses, a move paired with fresh earnings results and 2026 guidance. See our latest analysis for Genuine Parts. At a share price of US$119.26, Genuine Parts has seen a 2.05% 1 day share price return and a 1.02% 7 day share price return, but a 14.83% 30 day share price decline. The 1 year total shareholder return of 1.43% decline and 24.77% 3 year total...

If you are wondering whether LTC Properties is offering fair value at today's price or if the market is mispricing this healthcare REIT, this article walks through the key signals so you can judge for yourself. Over the recent periods, LTC's share price closed at US$39.68, with returns of 2.0% over 7 days, 12.6% over 30 days, 14.5% year to date, 21.2% over 1 year, 36.7% over 3 years, and 29.7% over 5 years. Recent attention around LTC has centered on its position in senior housing and...

AbbVie (ABBV) just combined a fresh FDA approval in blood cancer with a US$380 million manufacturing build out in Illinois, giving investors new information on both its product portfolio and long term capacity plans. See our latest analysis for AbbVie. Those updates on cancer drugs and manufacturing come alongside a 1 month share price return of 6.13% and a 1 year total shareholder return of 14.75%. The 3 year total shareholder return of 65.74% suggests momentum has been building over time...

Icahn Enterprises (NasdaqGS:IEP) reported Q4 results that included strong performance from its investment funds. The company recorded a decline in net asset value linked to CVI while shifting its portfolio toward more defensive assets. Icahn Enterprises announced a new CEO for its Food Packaging segment to lead a transformation of that business. The group also outlined actions to support liquidity and reduce debt across its operations. Icahn Enterprises is a diversified holding company with...

If you are wondering whether Electronic Arts at around US$200.57 is priced for perfection or still offers value, you are not alone. This article will help you frame that question clearly. The stock has been relatively steady in the short term, with a 0.1% return over 7 days and a 1.7% decline over 30 days. The 1 year return of 56.0% and 3 year return of 80.0% may be shaping how investors think about both upside and risk. Recent news coverage has focused on Electronic Arts as a major player...

If you are wondering whether Applied Industrial Technologies at around US$282.58 is priced for perfection or still offers value, you are in the right place. The stock has seen returns of 0.2% over the last 7 days, 10.3% over 30 days, 8.8% year to date, 13.6% over 1 year, 100.4% over 3 years and 222.7% over 5 years, which naturally raises questions about what is already reflected in the share price. Recent coverage has focused on Applied Industrial Technologies as a key player in the capital...

Goodyear Tire & Rubber (NasdaqGS:GT) was a plaintiff in a recent U.S. Supreme Court case that limited the federal government's ability to impose tariffs under emergency powers. The ruling affects how future tariffs may be applied to imported goods, a key consideration for companies with global supply chains such as Goodyear. Separately, Goodyear will have a prominent role in the upcoming IROC Heritage Invitational, featuring legendary NASCAR drivers and a revival of the IROC brand. The event...

Calumet (CLMT) closed out FY 2025 with Q4 revenue of US$1,038.6 million and a basic EPS loss of US$0.43, alongside a trailing twelve month revenue base of US$4.1 billion and a TTM EPS loss of US$0.39. Over recent quarters, revenue has ranged from US$993.9 million to US$1,078 million while quarterly EPS has swung between a loss of US$1.87 and a profit of US$3.61, so this latest print keeps the story focused squarely on how efficiently that revenue is being converted into earnings. With the...

InterDigital announced a collaborative 6G sensing achievement with Türk Telekom, using preliminary 6G architecture for cellular and Wi-Fi sensing. The company also signed a new global patent license agreement with Sony that applies to all Sony end-user devices. These developments highlight both InterDigital's technology progress in 6G sensing and the expansion of its recurring licensing revenue base. InterDigital, listed as NasdaqGS:IDCC, is drawing attention with these twin announcements...

In February 2026, Freshpet reported fourth-quarter 2025 sales of US$285.23 million and net income of US$33.82 million, capping a full year in which sales reached US$1.10 billion and net income rose to US$139.14 million. The company highlighted record net sales, higher earnings per share, margin expansion and positive free cash flow, while guiding to a slower 7%–10% net sales growth range for 2026. We’ll now examine how Freshpet’s record 2025 profitability and more measured 2026 sales outlook...

RLX Technology (RLX) is drawing fresh investor attention after hedge funds increased their exposure, while recent analyst downgrades highlighted ongoing regulatory and pricing pressures in the e vapor market. See our latest analysis for RLX Technology. At a share price of US$2.42, RLX has posted a 1 day share price return of 0.83%, a 7 day share price return of 2.11% and a 30 day share price return of 2.98%. The 90 day share price return shows a decline of 3.59%, which contrasts with a modest...

HP (HPQ) is back on investors’ radar after recent share price moves, with the stock now around $18.99 and mixed returns over the past month and past 3 months prompting closer attention. See our latest analysis for HP. While HP’s 1 day share price return of 0.96% and 7 day share price return of 2.15% suggest a short term rebound at US$18.99, the 90 day share price return decline of 22.24% and 1 year total shareholder return loss of 35.76% point to weaker momentum over the longer run. If HP’s...

MoonLake Immunotherapeutics reported positive topline Phase 2 results for Sonelokimab in axial spondyloarthritis. The company plans to move Sonelokimab into Phase 3 trials, supported by recent regulatory feedback. MoonLake is preparing for a future Biologics License Application and expanding development and manufacturing partnerships. MoonLake Immunotherapeutics, listed as NasdaqCM:MLTX, is drawing fresh attention after the Sonelokimab Phase 2 readout in axial spondyloarthritis and plans...

Golar LNG pivots to an exclusive FLNG service model, fully exiting LNG shipping after 50 years. The company secures a 20 year FLNG contract in Argentina and reports record operational and financial results. New fleet deployment, including the commencement of FLNG Gimi, supports a larger contracted backlog and longer term cash flow visibility. Golar LNG, traded as NasdaqGS:GLNG, is reshaping its business around FLNG services with no remaining exposure to traditional LNG shipping. The shares...

Chubb (CB) is back in focus after reporting fourth quarter 2025 results that beat analyst earnings expectations and proposing a higher quarterly dividend for the 33rd consecutive year, along with record investment income. See our latest analysis for Chubb. Those earnings and dividend announcements come after a strong run in the shares, with a 30 day share price return of 12.25% and a 1 year total shareholder return of 20.98%, building on a 5 year total shareholder return of 114.49%. If...

Ellington Financial (NYSE:EFC) is acquiring a residential mortgage servicer as part of a move toward greater vertical integration. The company is expanding its investment portfolio beyond its existing holdings in mortgage and consumer credit assets. Ellington Financial has issued unsecured notes and completed multiple securitizations as part of a broader capital structure update. Ellington Financial, a specialty finance company listed on the NYSE under the ticker EFC, focuses on...

If you are wondering whether Gilead Sciences is priced attractively today, this article walks through what the current share price might imply about its underlying value. With the stock at US$148.95, recent returns range from a 1.6% decline over the last 7 days to gains of 6.6% over 30 days, 22.5% year to date, 33.9% over 1 year, 104.2% over 3 years, and 179.3% over 5 years. This naturally raises questions about what is already reflected in the price. Recent headlines around Gilead Sciences...

Kohl’s Board of Directors recently declared a regular quarterly dividend of US$0.125 per share, payable on April 1, 2026, to shareholders of record as of March 18, 2026. This routine payout comes as Kohl’s turnaround story, activist interest, and real estate optionality have pushed its business prospects back into the spotlight. Next, we’ll examine how this dividend affirmation, alongside perceived turnaround momentum, may influence Kohl’s existing investment narrative. The best AI stocks...

Investor Ed Garden is pressing for leadership changes at Fortune Brands Innovations, challenging the incoming CEO and urging a refreshed board. The campaign focuses on new director nominees and opposition to the planned management transition at NYSE:FBIN. This push introduces fresh questions around the company’s future direction and governance priorities. For you as an investor, the headline is that a high profile shareholder is openly contesting how Fortune Brands Innovations is being run...

Millicom International Cellular (NasdaqGS:TIGO) closed FY 2025 with fourth quarter revenue of US$1.7b and basic EPS of US$1.51, alongside net income from ongoing operations of US$252m. The company reported quarterly revenue of US$1.43b in Q4 2024, US$1.37b in Q1 2025, US$1.37b in Q2, US$1.42b in Q3 and US$1.65b in Q4 2025. Over the same period, basic EPS ranged from US$0.20 to US$4.05. This set of results highlights the role of richer margins and a sizeable one off gain in shaping how...

With no single headline event driving attention today, Tyson Foods (TSN) is on some investors’ radar after a recent share price move, short term gains and modest longer term total returns. See our latest analysis for Tyson Foods. The recent 2.17% 1 day share price return, alongside an 11.97% year to date share price return and a 9.70% 1 year total shareholder return, points to building momentum rather than a short lived bounce. If Tyson Foods has you rethinking where growth and income might...

Bausch + Lomb (BLCO) is back in focus after reporting record Q4 2025 revenue and adjusted EBITDA growth, supported by pharmaceuticals, premium intraocular lenses, contact lenses, and the Vision 27 margin improvement program. See our latest analysis for Bausch + Lomb. The record Q4 figures, guidance for 2026 revenue in the US$5.375b to US$5.475b range and fresh clinical attention on products like LUMIFY sit against a share price of US$18.30, with a 30 day share price return of 9.19% and a 1...

With no specific headline event driving Slide Insurance Holdings (SLDE) today, recent trading and fundamentals provide more of the story. The stock last closed at $19.00, with mixed short term returns. See our latest analysis for Slide Insurance Holdings. The recent 7 day share price return of 12.6% and 30 day share price return of 18.9%, on top of a positive 90 day share price move, point to building momentum despite a softer 1 day pullback. If this kind of move has you looking beyond a...

If you are wondering whether Public Storage is fairly priced at around US$307 a share, you are not alone; many investors are trying to work out what they are actually paying for here. The stock has recently posted returns of 0.7% over 7 days, 12.1% over 30 days, 18.8% year to date, 5.4% over 1 year, 13.9% over 3 years, and 61.9% over 5 years, which is prompting fresh questions about both growth potential and risk. Recent coverage has focused on Public Storage as a major US self storage REIT,...